Vivalytic Viral Respiratory Tract Infections (VRI)
Point of Care Testing Device
Information
The Vivalytic Viral Respiratory Tract Infections (VRI) Test is a PCR-based diagnostic panel designed to detect 10 common viral respiratory pathogens, including SARS-CoV-2, Influenza A/B, RSV, Adenovirus, and MERS-CoV. Using nasopharyngeal or oropharyngeal swab samples (eNAT), it employs Randox Biochip Technology (end-point PCR) to provide comprehensive respiratory virus screening, including co-infections. With a time to result of 2 hours 30 minutes, this test supports accurate and informed treatment decisions for respiratory infections.
